Search PubMed⌕ Search

Biomedical subjects

T Mikami

Publications and source records attributed to T Mikami.

At least 523 records · Page 29Linked to original sources
PubMed1990

In vivo viscoelastic behavior in the human aorta.

To characterize the viscoelastic properties of the human aorta in vivo, the pressure-diameter relation was determined in the abdominal aorta in 15 subjects. Diameter was measured noninvasively with a highly sensitive ultrasonic displacement meter, while intra-aortic pressure was measured with a catheter tip micromanometer inserted from the femoral artery. The frequency-dependent changes in the pressure-strain modulus (Ep) of the aorta and the phase lag of diameter to pressure were calculated by frequency analysis of these wave forms at the mean blood pressure of 109 mm Hg. The Ep and the phase lag at the fundamental frequency component (1.2 +/- 0.3 Hz, mean +/- SD) were (1.52 +/- 0.57) x 10(6) dyne/cm2 and -6.7 degrees +/- 2.1 degrees, respectively. Although the phase lag at the fundamental frequency was in good agreement with the published in vitro data, the calculated phase lags above the second harmonic were inconsistent, which was probably due to the nonlinearity in the pressure-diameter relation. To separate the effect of this nonlinearity, analysis was conducted with a model consisting of a static nonlinear component representing the elasticity and a dynamic linear component representing the viscosity. This method of analysis revealed that the phase lag due to the viscous component provided relatively flat frequency response to the 10th harmonic. It was confirmed that the aortic wall viscosity showed no apparent difference between the in vivo and the in vitro experimental conditions.

Adult↗
PubMed1990

Restriction endonuclease analysis of canine herpesviruses isolated in Japan.

Eighteen canine herpesvirus (CHV) isolates from Japan and two reference strains were compared by restriction endonuclease analysis technique using total DNA extracts from cells infected with the viruses. In order to select the suitable restriction endonucleases for differentiation of CHV isolates, ten enzymes were used and three of them, HindIII, XbaI, and PvuII, were found to be useful for strain differentiation. With these enzymes, CHV isolates from unrelated individuals were readily differentiated from each other. In contrast, all the isolates derived from the same litter were not distinguishable on the basis of restriction cleavage patterns. However, slight mobility shifts were observed among the isolates from the same litter or the same individual. The results showed that this method provides a powerful tool for epidemiological surveys of CHV infection.

Animals↗
PubMed1990

Preparation and characterization of neutralizing monoclonal antibodies to feline calicivirus.

Fourteen neutralizing monoclonal antibodies (N-MoAbs) were prepared against the F4 strain of feline calicivirus (FCV), the prototype strain of FCV in Japan, and examined for their ability to neutralize FCV isolates. Neutralization-resistant variants of the F4 strain were selected under the presence of 4 individual N-MoAbs in cell culture systems and used in cross-neutralization tests and enzyme-linked immunosorbent assay with all of the 14 N-MoAbs. The results revealed the identification of at least two antigenic determinants on FCV F4: one being more broadly conserved among FCV isolates than the other. Usefulness of antigenic variants resistant to N-MoAbs for analysis of neutralization determinants on FCV was also demonstrated.

Antibodies, Monoclonal↗
PubMed1990

Evaluation of pathogenicity and protective efficacy of serotype 2 Marek's disease virus from birds belonging to genus Gallus in Japan.

The new cloned serotype 2 Marek's disease viruses (MDV) of ML-6, ML-9, and ML-22 strains were inoculated in specific-pathogen-free (SPF) chicks to evaluate the pathogenicity and protective efficacy. Chicks inoculated or contact-infected with ML strains showed no gross and histological lesions in lymphoid organs, sciatic plexuses and other visceral organs during 10 weeks of observation periods, indicating that the viruses were non-pathogenic. Moreover, the viruses were found to be spread horizontally among chicks by demonstrating the presence of viremia in contacted chicks at 2 weeks-old. Chicks vaccinated with ML-6 at one day-old were protected against subsequent challenge by inoculation with virulent MDV strain of Md/5 at 4 or 7 days old or by contact infection at 7 days old with chickens previously inoculated with the same strain.

Animals↗
PubMed1990

Intracellular localization and epitope mapping of feline herpesvirus type 1 glycoproteins.

Monoclonal antibodies (MoAbs) were used to characterize feline herpesvirus type 1 (FHV-1) glycoproteins (gp). Intracellular localization and transport of these proteins as revealed by a sequential indirect immunofluorescence assay (IFA) on fixed infected cells showed slight differences between FHV-1 gp143/108 and gp113. Antibodies against gp143/108 first showed membrane fluorescence at 4 hrs post-infection (PI) followed by a pronounced perinuclear and cytoplasmic staining from 8 hrs PI onwards. Those reacting with gp113 showed the same pattern but fluorescence did not appear until 8 hrs PI. In contrast, MoAbs against gp60 first showed para- and perinuclear staining at 12 hrs PI which became intranuclear at 16 hrs PI, followed by intracytoplasmic staining at 20 hrs PI. Sequential IFA of unfixed infected cells revealed that the three glycoproteins were expressed on the cell surface membrane as well. Topographical mapping of the functional epitopes of gp113 by ELISA additivity test indicated the presence of 2 antigenic domains--a neutralizing domain consisting of 3 overlapping epitopes and a non-neutralizing domain. On the other hand, gp143/108 contained only one antigenic site consisting of 5 similar or overlapping epitopes, one of which seemed to be a conserved region recognized by all MoAbs reacting to this protein.

Animals↗
PubMed1990

Canine herpesvirus 47 kD and mutated 41 kD glycoproteins are responsible for hemagglutination.

Monoclonal antibodies (MoAbs) were used to identify the hemagglutinin of canine herpesvirus (CHV). The inhibition of viral hemagglutination (HA) activity was observed with MoAbs against 41 kD glycoprotein, while no hemagglutination-inhibition (HI) activity was observed with those against 145/112 kD and 80 kD glycoproteins, suggesting that the 41 kD glycoprotein is the hemagglutinin of plaque-selected virus of CHV YP11 strain used as immunogen for MoAb production. All of the HI MoAbs also showed HI activities against HA antigens which were prepared from cells infected with other CHV strains, namely, F-205 V and Glasgow CHV2 reference strains, eight Japanese isolates, and the original YP11 strain. However, on immunoblotting analysis, a 47 kD protein band was detected in these strains by the HI MoAbs. These data suggest that the 47 kD glycoprotein is the common molecule of the hemagglutinin among CHV strains and the plaque-selected virus of YP11 strain appears to be a mutant whose molecular weight of the hemagglutinin changed into 41 kD.

Animals↗
PubMed1990

Characterization of the subunit particles of feline calicivirus.

In the culture fluid from cells infected with feline calicivirus (FCV) F4 strain, the infectious and smaller non-infectious subunit particles were detected by complement fixation (CF) test after sucrose gradient centrifugation. The results of sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot analyses confirmed the existence of the subunit particles of FCV, and showed that the infectious and subunit particles were mainly composed of 65K capsid protein. The subunit particles were further purified by ion-exchange chromatography and sucrose gradient centrifugation. The purified subunit and infectious particles had the same neutralizing epitope on 65K protein detected by immunoblot analysis with a neutralizing monoclonal antibody. Antigenic comparison between the infectious and subunit particles by the CF tests using an antiserum against heterologous strain of FCV F14 indicated that the subunit particles might have more highly conserved antigens of FCV than the infectious particles.

Animals↗
PubMed1990

Production and characterization of monoclonal antibodies against chicken lymphocyte surface antigens.

A panel of monoclonal antibodies (mAbs) with specificity for chicken lymphocyte surface antigens was established and characterized based on their reactivities against chicken lymphoid cells and tumor cell lines on flow cytometry. Three mAbs (7-3G-2, 7-2E-8, and JB-2) reacted preferentially with thymocytes, however, none of them reacted with Marek's disease derived T lymphoblastoid cell lines. Four mAbs (6-27A-1, 4-5C-5, Lc-4, and Lc-6) reacted with spleen cells and peripheral blood leukocytes as well as thymocytes. All seven mAbs reacted with chicken embryonic thymocytes from day 12 of embryonic life onward. All mAbs showed no reactivity against bursal lymphocytes.

Animals↗
PubMed1990

Identification of virus-specific antigens in cultured cells infected with Marek's disease virus serotype 2 and CVI-988 strain.

For the identification of serotype-specific antigens of Marek's disease virus (MDV) serotype 1 (MDV1) or serotype 2 (MDV2), a total of 24 hybridoma clones, secreting monoclonal antibodies (MAbs) against CVI-988 (MDV1) or HPRS-24 (MDV2) strain, were established and characterized by immunofluorescence assay, virus neutralization and immunoprecipitation analysis. Based upon the molecular weights (mol. wt.) of the immunoprecipitated polypeptides, the MAbs were subdivided into 7 groups. Among them, two groups of MAbs reacted with antigens that have not been reported, were identified. MAbs belonging to the first group reacted with CVI-988- and MDV2-specific antigens with mol. wt. ranging from 29 K to 34 K (29/34 K). This antigen was not found in cells infected with Md/5 and JM strains of MDV1, and the results of kinetic analysis of antigen expression showed this antigen appeared to be related to late membrane antigens. MAbs belonging to the second group immunoprecipitated MDV2-specific antigens with mol. wt. of 37 K, 33 K and 31 K from HPRS-24-infected cells or with those of 37 K, 34 K and 31 K from SB-1(MDV2)-infected cells, and these antigens appeared to be related to early antigens. MAbs belonging to the other 5 groups included those which recognized similar antigens reported previously or the antigens characterized insufficiently in this study.

Animals↗
PubMed1990

Magnetic resonance imaging of Chiari malformations.

The authors describe the features of magnetic resonance (MR) images of Chiari type I and II malformations and present four illustrative cases. Downward displacement of the posterior fossa was more pronounced with type II than type I. A variety of intracranial anomalies were associated with the Chiari type II malformation, whereas type I was mainly associated with syringomyelia and craniovertebral changes. MR imaging is useful in the diagnosis of intracranial anomalies and those situated at the craniovertebral junction, including Chiari malformations.

Adult↗
PubMed1990

[Mode of hypertrophy in hypertrophic cardiomyopathy based on the external shape of the left ventricle: a two-dimensional echocardiographic study].

To assess the mode of left ventricular hypertrophy in hypertrophic cardiomyopathy (HCM), two-dimensional echocardiography was performed in 15 patients with asymmetric septal hypertrophy and in 13 normal subjects. The long-axis diameter (LxD) was defined as the distance from the midpoint between the anterior annulus of the aortic valve and the posterior annulus of the mitral valve to the apex in the apical long-axis image. In the parasternal long-axis image, the long axis of the left ventricle (LV) was determined by overlaying the parasternal image on the apical image. The external diameter (ExD) and the internal diameter (InD) of the LV at chordal level were measured in the direction of the short axis. The anterior part (-a) and the posterior part (-p) of both ExD and InD, which were divided by the long axis, were also measured. LxD, ExD, ExD-a, ExD-p and InD-p in HCM were greater than those in the normal subjects. Thus, the interventricular septum (IVS) in HCM was thickened inwardly and outwardly. In contrast, the left ventricular posterior wall (PW) in HCM showed only outward deviation. Thickness of the IVS and PW, and the excursion of the PW in HCM were greater than those in the normals, but the excursion of the IVS in HCM was smaller than those in the normals. We concluded that outward expansion of the IVS and PW occurs in HCM and distinct narrowing of the LV occurs only on the septal side in HCM.(ABSTRACT TRUNCATED AT 250 WORDS)

Adolescent↗
PubMed1990

[Difference in the therapeutic efficacy between anaplastic astrocytoma and glioblastoma multiforme types].

We have investigated the differences in therapeutic efficacy between 25 cases with an anaplastic astrocytoma (AA group) and 31 cases with a glioblastoma multiforme (GM group). A good response to induction therapy was achieved with radiation and nitrosourea after a (sub) total removal that led to a prolonged tumor-free interval that was remarkable in the AA group, especially in those with moderate anaplastic astrocytoma. On the other hand, in the GM group, early recurrence tended to occur with no correlation to the degree of the tumor resection, and this made the execution of the maintenance therapy difficult in spite of a similar response to the initial induction therapy as that seen in the AA group.

Adult↗
PubMed1990

Catheter-type defibrillation electrode using glassy carbon: results of electrode implantation.

The implantable defibrillator, developed by Dr Michel Mirowski, is a remarkable electric therapeutic device which has been in clinical use since 1980 in the treatment of life-threatening arrhythmia. However, as the present life span of this device is only 3 years, research is being carried on to extend the lifetime with improved stimulation methods, circuits and electrodes. In particular, the electrode system which is inserted into the right ventricle has more than 50 times the electrode area of a pacing electrode and is prone to degradation. What is needed is biocompatibility and electrical stability, similar to that of cardiac pacemaker electrodes, which can be used for more than 10 years. For this purpose, we focused on a conductive ceramic as a new material for the defibrillation electrode instead of the previously-used metal. We selected glassy carbon as our electrode material and tested the surface condition through acute and chronic animal experiments. No clots formed around the electrodes after a 3-month implantation, nor were there surface disorders after the defibrillation stimulations. We concluded that glassy carbon is a promising material for future defibrillation electrodes.

Animals↗